データなし
默沙东(MRK.US)终止开发抗TIGIT抗体和抗LAG-3抗体
智通財経12/17 21:09
价值20亿美元!翰森制药授予默沙东口服减肥药全球独家许可权
cls.cn12/18 22:08
Merck (MRK) Stock Moves -1.72%: What You Should Know
Zacks 06:00
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Benzinga03:29
Sector Update: Health Care Stocks Advance in Afternoon Trading
MT Newswires02:49
Sector Update: Health Care
MT Newswires02:34